Vai al contenuto
HPB-ALL
Tessuto
Peripheral blood
Malattia
Precursor T-cell acute lymphoblastic leukemia
Sito metastatico
Peripheral blood (systemic T-ALL)
Sinonimi
HPB/ALL, HPBALL, FCCH1018

Documenti

HPB-ALL

Cell line · Codice prodotto 302895

HPB-ALL è una linea cellulare derivata da una leucemia linfoblastica acuta a cellule T precursori umane (T-ALL), ottenuta dal sangue periferico di un ragazzo giapponese di 14 anni...

€430.00IVA e spese di spedizione escluse

Personalizzazione / Suggerimenti

Disponibile
Lotto
Consigliati (partita più recente)
  • CoA
1

01Informazioni generali

Descrizione

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Tessuto
Peripheral blood
Malattia
Precursor T-cell acute lymphoblastic leukemia
Sito metastatico
Peripheral blood (systemic T-ALL)
Applicazioni
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinonimi
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Classificazione

Organismo
Umano
Sesso
Maschio
Proprietà di crescita
Sospensione
Livello di biosicurezza
1

03Caratteristiche

Morfologia
Lymphoblast-like
Tipo di cellula
T-cell
Tempo di raddoppio
~50 hours

04Identificatori

Riferimento bibliografico
HPB-ALL (Cytion catalog number 302895)
Codice fiscale NCBI
9606
Cellosaurus
CVCL_1820

05Espressione e suscettibilità

Profilo mutazionale
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Manipolazione e coltura

Terreno di coltura
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Integratori
Supplement the medium with 10% FBS
Reagente di dissociazione
dilution
Subcoltura
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Rapporto di frazionamento
1 : 10 split
Densità di semina
3-5*10^5/ml
Rinnovo dei fluidi
Subculture : 2 times/week
Scongelamento e coltura
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Controllo di qualità e crioconservazione

Terreno di coltura congelato
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condizioni di conservazione

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Condizioni di spedizione

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donatore

Età dei donatori
14 years
Etnia
Japanese

10Dettagli sul prodotto

Tabella delle composizioni